Bausch Health Companies | VRX - Заемный капитал

Биржевая цена
7.85
Изменение за день
-0.04 -0.51%
Ежемесячно
14.10%
Ежегодный
24.21%
Q2 прогноз
7.59




Заемный капитал Изменить Дата
Amgen USD 50B 2.43B 2025-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zoetis USD 9.04B 1.97B 2025-12